Functional Expression of Organic Cation/carnitine Transporter 2 (OCTN2/SLC22A5) in Human Brain Capillary Endothelial Cell Line hCMEC/D3, a Human Blood-brain Barrier Model

The aim of this study was to examine whether organic cation/carnitine transporter 2 (OCTN2/SLC22A5) plays a role in the human blood-brain barrier (BBB) by evaluating its functional activity in human brain endothelial cells (hCMEC/D3), which are considered to be a model of the BBB. The uptake of [3H]...

Full description

Saved in:
Bibliographic Details
Published inDRUG METABOLISM AND PHARMACOKINETICS Vol. 29; no. 1; pp. 69 - 74
Main Authors Okura, Takashi, Kato, Sayaka, Deguchi, Yoshiharu
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 2014
Japanese Society for the Study of Xenobiotics
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The aim of this study was to examine whether organic cation/carnitine transporter 2 (OCTN2/SLC22A5) plays a role in the human blood-brain barrier (BBB) by evaluating its functional activity in human brain endothelial cells (hCMEC/D3), which are considered to be a model of the BBB. The uptake of [3H]L-carnitine by hCMEC/D3 cells was time-, extracellular sodium- and concentration-dependent, with a Km value of 15.7 μΜ. These results are consistent with the properties of OCTN2-mediated L-carnitine transport. hCMEC/D3 cells showed relatively high expression of OCTN2 mRNA, and this expression was effectively decreased at 24-72h after lipofection of cells with OCTN2 siRNA under optimized conditions. [3H]L-Carnitine uptake was dramatically suppressed by silencing of the OCTN2 gene. The inhibitory effect of OCTN2 gene silencing was similar to that of an excess amount of unlabeled L-carnitine. These results indicate that OCTN2 is involved in L-carnitine transport at the human BBB.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1347-4367
1880-0920
1880-0920
DOI:10.2133/dmpk.DMPK-13-RG-058